chondroitin sulfate + hyaluronic acid + aluminium hydroxide Tablets, orally disintegrating (ODT)

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Gastrointestinal system
Product description
Indicated in symptomatic treatment of Gastroesophageal Reflux Disease (GERD) and hyper-acidity.
Unavailable markets
Ukraine
Manufacturer #6338
This international pharmaceutical company boasts over 75 years of experience in research, development, and manufacturing of innovative medications across various therapeutic areas. Their product portfolio encompasses specialty care, primary care, and consumer care products, with a particular focus on Gastroenterology. Other key therapy areas include Vascular, Rheumatology, Metabolic, Nutraceuticals & Medical foods. The company operates production facilities in Italy, Spain, and the United States, along with R&D centers in Italy. They hold licenses and GMP certifications for prescription medications, over-the-counter drugs, and medical devices, demonstrating a commitment to quality and regulatory compliance. In addition to its own product lines, the company provides contract manufacturing services to other pharmaceutical companies.

Manufacturer usually replies in 22 days

None